For example, based on a query of the Clinicaltrials.gov data-base, 5 trials have proposed to test the use of TGFβ inhibitory agents in gastrointestinal cancers, including in pancreatic cancer patients. Here, TGFB1 is linked to pancreatic neoplasm.